Diabetic Foot Infections & Ulcers

Epidemiology & Risk Factors

  • Pathogenesis: Triad of peripheral neuropathy (loss of protective sensation to minor trauma) + peripheral artery disease (PAD) (impaired healing) + immunopathy (hyperglycemia-induced impaired neutrophil function).
  • Risk Factors:
    • Longstanding DM2/DM1 w/ poor glycemic control (HbA1c > 8-10%).
    • Prior foot ulceration or lower extremity amputation.
    • Diabetic peripheral neuropathy (distal symmetric polyneuropathy).
    • Foot deformities (Charcot foot, hammer/claw toes, hallux valgus).
    • Chronic kidney disease (CKD), smoking, or underlying PAD.
  • Microbiology:
    • Superficial/Mild: Monomicrobial (S. aureus, S. pyogenes).
    • Deep/Chronic/Severe: Polymicrobial (S. aureus, MRSA, Streptococci, Gram-negative bacilli [P. aeruginosa], anaerobes [Bacteroides]).

Clinical Features

  • History:
    • Painless skin break/ulcer (due to loss of pain sensation).
    • Delayed recognition; foot deformities causing unnatural pressure points.
    • Intermittent claudication or rest pain (if concomitant PAD).
  • Physical Exam:
    • Location: Weight-bearing bony prominences (e.g., plantar 1st/5th metatarsal head, heel, tips of toes).
    • Ulcer Appearance: Punched-out lesion surrounded by hyperkeratotic callus.
    • Infection Signs: Erythema (>2 cm suggests moderate/severe infection), warmth, purulence, foul odor, crepitus (gas-forming anaerobes).
    • Systemic Signs: Fever, chills, tachycardia, altered mental status (may be absent even in severe infection due to blunted immune response).
    • Charcot Joint: Loss of sensation -> repeated trauma -> collapse of foot architecture -> “rocker-bottom” foot.

Diagnosis

  • Screening/Bedside Tests:
    • 10-g Semmes-Weinstein Monofilament Test: Evaluates loss of protective sensation (distal polyneuropathy).
    • Probe-to-Bone (PTB) Test: Insert sterile metal probe into ulcer base; feeling hard, rigid bone strongly correlates w/ osteomyelitis (high PPV).
  • Key Labs:
    • Inflammatory Markers: ESR > 70 mm/hr strongly supports osteomyelitis. Elevated CRP/WBC.
    • Microbiology: Deep tissue culture obtained after debridement (superficial wound swabs are WRONG as they reflect colonizers).
    • Blood cultures if septic/systemic signs present.
  • Imaging:
    • Initial: Plain X-ray of foot to rule out subcutaneous gas, foreign body, cortical erosion, or periosteal reaction (osteomyelitis findings take 2-3 weeks to appear).
    • Confirmatory / Gold Standard Imaging: MRI of the foot (most sensitive test for acute/early osteomyelitis and soft tissue abscess).
  • Vascular Assessment:
    • Ankle-Brachial Index (ABI): Assess for PAD. Note: Calcification (Mönckeberg) can falsely elevate ABI (> 1.4); use Toe-Brachial Index (TBI) or arterial duplex US instead.

Differential Diagnostics

  • Venous Stasis Ulcer:
    • Diff: Located over medial malleolus, irregular shallow borders, hyperpigmentation (hemosiderin deposition), stasis dermatitis, pain improved with leg elevation.
  • Arterial / Ischemic Ulcer:
    • Diff: Located at distal extremities/tips of toes, extremely painful, cold leg, shiny pale skin w/ loss of hair, absent distal pulses, pain worsened by elevation.
  • Uninfected Neuropathic Ulcer:
    • Diff: Ulcer w/ callus border, lack of surrounding erythema (< 0.5 cm), no purulence, normal ESR/CRP, negative PTB test.
  • Acute Charcot Arthropathy (Non-infected):
    • Diff: Warm, red, edematous foot without open skin ulcer or purulent discharge; negative PTB test and ESR usually normal/mildly elevated.

Management

  1. Immediate Emergency / Systemic Stabilization:
    • Hemodynamic support (IVF, broad-spectrum IV Abx) if septic.
  2. Antibiotic Therapy:
    • Mild Infection (superficial, local erythema < 2 cm): Oral Abx covering S. aureus & Streptococcus (e.g., Cephalexin, Augmentin; add Bactrim/Doxycycline for MRSA).
    • Moderate/Severe or Deep Infection / Osteomyelitis: IV broad-spectrum empiric coverage against MRSA + Gram-negatives + Anaerobes (e.g., Vancomycin + Piperacillin-Tazobactam [Zosyn] or Vancomycin + Cefepime + Metronidazole).
    • Adjust Abx based on deep tissue cultures; treat osteomyelitis for 4-6 weeks.
  3. Surgical Intervention:
    • Debridement: Operative clearance of necrotic tissue, callus, and infected bone (essential for healing).
    • Drainage: Emergency incision & drainage for abscesses or gas gangrene.
    • Amputation: Reserved for refractory osteomyelitis, extensive tissue necrosis, or non-revascularizable ischemia.
  4. Offloading & Wound Care:
    • Offloading: Pressure relief w/ Total Contact Casting (TCC) or specialized orthotic boots (gold standard for neuropathic ulcers).
    • Moist wound environment dressings; hyperbaric oxygen therapy (refractory non-healing ulcers w/ severe ischemia).
  5. Adjunctive Measures:
    • Glycemic control (optimizing HbA1c < 7%).
    • Vascular consult for revascularization (endovascular angioplasty or surgical bypass) if severe PAD present (ABI < 0.5 or non-healing ulcer).

Complications

  • Osteomyelitis (occurs in up to 20-60% of deep ulcers).
  • Soft Tissue Abscess & Tenosynovitis.
  • Necrotizing Fasciitis / Gas Gangrene (surgical emergency).
  • Sepsis and Bacteremia.
  • Lower Extremity Amputation (major cause of non-traumatic amputation).